Page Heading
Current TPP Negotiations Focus on IP Protection
Tuesday, September 13, 2011 5:02 pm | By Kelsey Zahourek

While much of the current trade focus is on the push to pressure the Administration to submit the pending free trade agreements with South Korea, Colombia, and Panama, efforts to negotiate future agreements are currently underway, namely the Trans Pacific Partnership Agreement (TPP).

This week, the 8th round of trade negotiations on the TPP is being held in Chicago and a top agenda item is intellectual property protection, particularly in the area of pharmaceuticals. To coincide with the current trade round, a group of 37 Senators, led by Sens. Hatch and Kerry, sent a letter to USTR Kirk urging the Administration to maintain strong IP standards in the agreement and specifically calling for the baseline for data exclusivity on biologics to be consistent with U.S. law, meaning a minimum of 12 years.

Earlier this year, PRA echoed these same sentiments in a letter to USTR Kirk and Members of Congress stating:

“The US currently has one of the strongest and fastest growing biotech and pharmaceutical industries in the world. Weakening of IP rights not only is detrimental to the economy, but also puts the public’s health and safety at risk. Drugs being researched and manufactured today have been proven effective against life threatening diseases like cancer, multiple sclerosis and diabetes due to reliable patent laws that encourage innovation. Research and development is very expensive, and companies need to have an incentive to keep inventing life-saving drugs. Any trade agreement negotiated by the United States must include an IP chapter that provides for an adequate data protection period in order for research companies to recoup the costs of research and development.”

There are many in NGO community that have long opposed strong intellectual property protections in trade agreements, believing it drives up the cost of medicines and is the main reason why most people in poor countries have little or no access to medicines. However, when looking a little closer, the high price of drugs in poor countries has less to do with intellectual property and more to do with trade barriers and regulations, such as high tariffs and taxes.

As part of their efforts, the Office of the United States Trade Representative released a white paper laying the groundwork for a new strategic initiative titled, “Trade Enhancing Access to Medicines.” The paper outlines several goals including eliminating tariffs on medicines, reducing internal barriers to distribution of medicines, and curbing the trade in counterfeit medicines.

While no one denies the importance of delivering safe, affordable drugs to the world’s poor, the route by which many are calling to take is paved with harmful consequences that affect the future of research and development on these critical drugs. The medicines that patients are using today, whether patented or generic are available because of laws that encourage innovation. This type of international cooperation will go a long way in providing life saving medicines to those that need it the most while promoting innovation for the next generation of drug research and development.


Tags: IntProp DrugImp | Permalink | Comments

Knocked my socks off with kwonledge!
India / ldGxOYAhDGc October 28, 2011 28:22 am

This site is like a classroom, ecxpet I don't hate it. lol
Gertrude / tHfUAdyW November 26, 2011 26:57 pm

x1gWvF mgnpldmndvna
hcmzztg / eXKhbfXldVnVU November 28, 2011 28:31 am

EG6EvV , [url=]wtwsfkpyfqyb[/url], [link=]auujjlggcnff[/link],
aecwphlkle / CFFUTYnhX November 29, 2011 29:26 am

qDJ8s6 klxujsjzgdas
vysjvgri / gTmAdrTJxjlhfcuzfEP December 2, 2011 2:50 am

Can’t get legal aid, and attorney’s cost too much? If you have a legal problem – we have the solution. Best of all its FREE – Visit today.
Ran Rhaine / Philippines April 10, 2012 10:02 am

A facile arngmeut indeed. I think part of it comes down to the idea that Japanese products rice comes to mind are seen as superior to imports. I get the feeling that whether they could pass a taste test or not, many Japanese couldn't bear to make the switch to Chinese or Korean rice. Nearly identical, but lacking in that area of Yamato self-importance.Besides, if the Japanese really DO care enough about where their food comes from, they'll continue to purchase home-grown rice even as prices rise.
Jose / kAekGnlDox September 28, 2013 28:40 pm

Yes. I don't check for the organic seal, but I do use naratul and non toxic beauty products. I also avoid Sodium Laurel Sulfate, which technically is naratul, derived from palm, but it not good for the skin and is responsible for rain forest destruction.I use the skin deep cosmetics data base to research which known and suspected hazards are in various products.
Ulisses / ZMjioT7ERfY September 30, 2013 30:14 am

Psilocybin, by far, as supported by mutilple studies with very well-established procedures and methods, has been found to be the safest drug of all, even safer than cannabis by far. Tolerance to the drug develops more rapidly than tolerance to any other drug (a hair faster than to other hallucinogens like LSD, and much faster than the class of drugs most commonly associated with the fastest tolerance the opioids/painkillers). Therefore, its effects on the brain and thus damage, are by definition self-limiting. Additionally, it works only on the serotonin system, and is actually quite a mild agent. It is not neurotoxic works by mimicking serotonin, but has no adverse chemical reactive effects on the membranes of pre- or post-synapses. It is safe, even in prolonged use: that is the bottom line. Feel free to ask more questions as they come to you
Ramshad / ui1XfhpqnaS October 17, 2013 17:56 pm

Wow, this is in every repsect what I needed to know. [url=]xtuuyo[/url] [link=]laadah[/link]
Nelle / fJTyJlmQXNPx October 20, 2013 20:27 am

Add a comment
Your email address will not be displayed but will be added to our contact database. If you do not wish us to contact you, please leave that field blank.
Name:     Comment: